Innovent Biologics (suzhou) Co. Ltd.

This study tested a drug called GFH925 in 334 people with advanced cancers that have a specific genetic change (KRAS G12C). The goal was to see if the drug is safe and can shrink tumors. Participants had lung, colorectal, or other solid tumors. The drug is taken as a pill and aim…

This study tested a new weekly injection called IBI362 against the existing drug semaglutide in 349 Chinese adults with early type 2 diabetes and obesity. The goal was to see which drug better helps lower blood sugar and achieve significant weight loss. Participants received eith…

This study tested a new medicine called IBI362 in 328 overweight or obese adults in China. Participants received weekly injections of different doses of IBI362 or a placebo for 24 weeks, while also following diet and exercise plans. The main goal was to see how much weight they l…

This early-phase trial tested a new drug called IBI133 in 19 adults with advanced solid tumors that cannot be removed by surgery or have spread. The main goals were to find a safe dose and check for side effects. Researchers also looked at how the drug moves through the body and …

This study tested a new drug called IBI112 in 150 people with moderate to severe ulcerative colitis, a condition that causes inflammation and sores in the colon. The goal was to see if IBI112 could help patients achieve remission (no symptoms) after 12 weeks of treatment. Partici…

This study looked at how well and how safely IBI311 works over a longer period for people with thyroid eye disease. It included 91 adults who had already finished a previous study on the same drug. The main goal was to see if the drug could reduce bulging of the eye by at least 2…

This study tested a new drug called IBI334 in 28 people with advanced solid tumors that could not be removed by surgery or had spread. The main goals were to check the drug's safety and see if it helps control the cancer. The study is now complete.

This study tested a new drug called IBI311 in 38 people with thyroid eye disease, a condition that can cause bulging eyes and discomfort. Participants received different doses of the drug to see if it could reduce eye bulging and improve symptoms. The goal was to find the best do…

This early-stage trial tested the safety and tolerability of a new drug called IBI362 in 36 Chinese adolescents aged 12 to 17 with obesity. Participants had not lost significant weight through diet and exercise alone. The study compared those who received the drug to those who re…

This study tested whether adding the immunotherapy drug sintilimab to standard chemotherapy helps people with advanced non-squamous non-small cell lung cancer live longer without their cancer growing. About 400 adults with this type of lung cancer took part. The results showed th…

This study tested a new combination of two drugs (IBI310 and sintilimab) against the standard drug sorafenib for people with advanced liver cancer who had not received prior treatment. The goal was to see if the combination could help patients live longer or shrink tumors more ef…

This early-stage study tested a new drug called IBI355 in 30 adults with primary Sjögren's syndrome, an autoimmune disease that causes dry eyes and mouth. The main goal was to check the drug's safety and how the body processes it. Researchers gave multiple doses to see if it coul…

This early-stage study tested the safety and tolerability of a new drug called IBI356 in 99 participants, including healthy volunteers and people with atopic dermatitis (a type of eczema). The main goal was to check for side effects and how the drug moves through the body. No cla…

This early-stage study tested a single dose of a new drug called IBI3002 in 52 healthy volunteers and people with mild to moderate asthma. The main goal was to check if the drug is safe and how the body processes it. Participants were randomly assigned to receive either the drug …

This early-stage study tested the safety of a new drug called IBI3002 in 44 healthy volunteers and people with asthma. Participants received either the drug or a placebo, and researchers monitored for side effects. The goal was to find safe dose levels and understand how the drug…